Create Budget Efficiencies with Hybrid Studies
With reduced Medical Affairs budgets, PAREXEL Access can help Medical Affairs professionals take budgets farther and provide support for their hybrid study approach. Joshua Schultz, Corporate VP and Head of PAREXEL Access explains how we help clients plan at a portfolio level, providing greater strategic advantage and the ability to identify greatest cost-efficiency for evidence generation. PAREXEL’s late stage evidence platform drives average cost savings of 20% by combining real-world database analyses and real-world prospective research, offering a lean development approach. This helps clients communicate value to all stakeholders including their internal stakeholders.